Search results
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown -...
Benzinga· 1 hour agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
KFGO· 6 hours agoBy Sam Tobin LONDON (Reuters) - Pfizer and BioNTech asked a London court to revoke rival Moderna's...
Better Buy: Pfizer vs. Viking Therapeutics
Motley Fool via Yahoo Finance· 7 hours agoAt the same time, several big pharma companies continue to offer attractive valuations and dividend yields. Image Source: Getty Images. Pfizer (NYSE:...
Pfizer (PFE) Rises Higher Than Market: Key Facts
Zacks via Yahoo Finance· 23 hours agoPfizer (PFE) closed at $26.26 in the latest trading session, marking a +1% move from the prior day. This move outpaced the S&P 500's daily gain of 0.87%....
Moderna, Pfizer/BioNTech set for UK court clash over COVID jab patents
Medical Xpress· 12 hours agoA row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday...
Rival Covid-19 jab developers face off in High Court patent trial
PA Media: Science via Yahoo News· 8 hours agoRival developers of Covid-19 jabs have faced off at the High Court in London as a weeks-long trial...
Sigma Planning Corp Lowers Stake in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 1 day agoSigma Planning Corp lowered its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 52.6% in the fourth quarter, according to its most recent 13F filing with the SEC ...
Levi Strauss, Pfizer, Goldman Sachs and Cigna Face Challenges from Conservative Shareholders
National Center for Public Policy Research· 6 hours agoProposals Target Donations to Radical Causes, Net Zero Plans and DEI Programs Washington, D.C. – Shareholder activists with the National Center for Public Policy Research’s Free Enterprise Project ...
Pfizer Options Trading: A Deep Dive into Market Sentiment - Pfizer (NYSE:PFE)
Benzinga· 1 day agoLoading... Loading... Financial giants have made a conspicuous bullish move on Pfizer. Our analysis of options history for Pfizer PFE revealed 18 unusual ...
EU regulators approve Pfizer antibiotic Emblaveo (NYSE:PFE)
Seeking Alpha· 1 day agoEU regulators have approved Pfizer (PFE) and AbbVie’s (ABBV) antibiotic product Emblaveo for the...
